Anidulafungin 100mg powder for solution for infusion vials
NHS hospitals in England used £18,210,528 of indicative cost of Anidulafungin 100mg powder for solution for infusion vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 3.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Anidulafungin 100mg powder for solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Anidulafungin 100mg powder for solution for infusion vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| King's College Hpl Nhs Foundation Trust | £1,793,442 |
| Manchester University Nhs Ft | £1,297,559 |
| Cambridge Univ Hosp Nhs Foundation Trust | £1,066,148 |
| Imperial College Healthcare Nhs Trust | £868,080 |
| University Hospitals Plymouth Nhs Trust | £742,114 |
| Sheffield Teaching Hospitals Nhs Trust | £651,202 |
| Guy's & St Thomas' Nhs Foundation Trust | £580,191 |
| London North West Healthcare Nhs Trust | £527,232 |
| East And North Hertfordshire Nhs Trust | £428,910 |
| Chelsea & Westminster Hospital Nhs Ft | £417,795 |
The primary-care picture
Anidulafungin is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Anidulafungin medicine page.